Biotech innovator Liquidia, specializing in pulmonary therapies, reported a notable insider sale amid continued growth in its ...

Wearable device data may help detect and track idiopathic pulmonary arterial hypertension, a rare lung disease, a study ...

Background Rapid access chest pain (RACP) clinics are designed to expedite cardiac assessment, but current pathways cause ...

Jennifer Kathleen Bosch has shared the story of her son André, who needed two major operations to treat a life-threatening ...

Greenock mum Jennifer Kathleen Bosch has shared the story of her son André, who needed two major operations to treat a ...

As altitude increases and oxygen levels drop, climbers on Kilimanjaro face physiological risks that can turn a straightforward hike into a dangerous situation.

Allrock Bio has dosed the first participants in a small clinical trial testing ROC-101 as an add-on treatment for pulmonary ...

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva,” the “Company” “we” or “us”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the ...

Statesman. The health beat takes her inside operating rooms, laboratories and clinics to tell the story of health care from a ...

New AI tools could screen existing CT scans to asses risk for heart disease. But, who'll pay for it, and will it improve ...

When health risks become visible in black and white, perspectives often shift. A study from Umeå University shows that when ...

A wireless implantable device that remotely monitors pulmonary artery pressure offers reliable safety and is linked to a significant reduction in the risk for heart failure-related hospitalisation.